Lexicon Pharma (LXRX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.34 --0%
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of $0.01, $0.10 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $28.86 million versus the consensus estimate of $6.49 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Venu Holding (VENU) PT Lowered to $8.70 at Freedom Broker
- S&P affirms Nvidia rating at AA on Ohio campus guarantee
- Estee Lauder (EL) call put ratio 1 call to 2.5 puts with a focus on 400 contracts of January 80 puts into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
